[Advanced radioiodine-refractory differentiated thyroid cancer]

Dtsch Med Wochenschr. 2015 Feb;140(3):168-71. doi: 10.1055/s-0041-100196. Epub 2015 Feb 6.

[Article in German]

Authors

Christine Spitzweg¹, Christoph J Auernhammer¹, Julia Geisler², Stefan Böck², Volker Heinemann², Peter Bartenstein², Burkhard Göke¹

Affiliations

¹ Medizinische Klinik und Poliklinik II, Klinikum der Universität München.
² Interdisziplinäres Schilddrüsenzentrum - Klinikum der Universität München (ISKUM), Comprehensive Cancer Center CCC der Ludwig Maximilians-Universität München.

PMID: 25658401
DOI: 10.1055/s-0041-100196

No abstract available

Publication types

Review

MeSH terms

Combined Modality Therapy
Disease Progression*
Humans
Iodine Radioisotopes / adverse effects
Iodine Radioisotopes / therapeutic use*
Molecular Targeted Therapy
Neoplasm Staging
Prognosis
Survival Rate
Thyroid Neoplasms / mortality
Thyroid Neoplasms / pathology
Thyroid Neoplasms / therapy*

Substances

Iodine Radioisotopes